APA (7th ed.) Citation

SM, P., L, R., V, G., F, K., T, V., & RGW, P. (2025). Proteomic Analysis of Substantia Nigra Reveals Molecular Insights Into the Neuroprotection Effect of Rosmarinic Acid Treatment in MPTP-Induced Mouse Model of Parkinson's Disease. Proteomics. Clinical applications, 19(3), e70006. https://doi.org/10.1002/prca.70006

Chicago Style (17th ed.) Citation

SM, Presti-Silva, Rodrigues-Ribeiro L, Gorshkov V, Kjeldsen F, Verano-Braga T, and Pires RGW. "Proteomic Analysis of Substantia Nigra Reveals Molecular Insights Into the Neuroprotection Effect of Rosmarinic Acid Treatment in MPTP-Induced Mouse Model of Parkinson's Disease." Proteomics. Clinical Applications 19, no. 3 (2025): e70006. https://doi.org/10.1002/prca.70006.

MLA (9th ed.) Citation

SM, Presti-Silva, et al. "Proteomic Analysis of Substantia Nigra Reveals Molecular Insights Into the Neuroprotection Effect of Rosmarinic Acid Treatment in MPTP-Induced Mouse Model of Parkinson's Disease." Proteomics. Clinical Applications, vol. 19, no. 3, 2025, p. e70006, https://doi.org/10.1002/prca.70006.